We have a new investigational research study evaluating the dose response of once-weekly injection in patients with Type 2 Diabetes between 18 and 64 years of age.

The total study participation is approximately 1 year.

If qualified, you may be compensated up to $1,110.00 for your time and travel. You will also receive study related care at no cost.

Qualified participants must:

  • Be a generally adult; 18-64 years of age
  • Have a BMI ≥0 kg/m2
  • Be diagnosed with Type 2 Diabetes
  • Have an HbA1c between 7.0-10.5%

Stay on track with clinical trials you can trust.

To see how we can provide the clinical trial and scientific consulting services you need, get in touch with us today.

  • This field is for validation purposes and should be left unchanged.